<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Entera Bio Ltd.

    Entera Bio Ltd.

    Entera Bio is a clinical-stage biopharmaceutical company focused on the developmen...

    Entera Bio is a clinical-stage biopharmaceutica...

    Filing Type:    PU
    ReWalk Robotics Ltd.

    ReWalk Robotics Ltd.

    ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company. We design,...

    ReWalk Robotics (Nasdaq: RWLK) is an innovative...

    Filing Type:    PU
    Masimo Corporation

    Masimo Corporation

    We are a global medical technology company that develops, manufactures, and market...

    We are a global medical technology company that...

    Filing Type:    PU
    CRISPR Therapeutics AG

    CRISPR Therapeutics AG

    We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...

    We are rapidly translating our specific, effici...

    Filing Type:    PU
    Cidara Therapeutics, Inc.

    Cidara Therapeutics, Inc.

    Cidara is a clinical-stage biotechnology company focused on the discovery, develop...

    Cidara is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    Quanterix Corporation

    Quanterix Corporation

    Quanterix is a company that is digitizing biomarker analysis with the goal of adva...

    Quanterix is a company that is digitizing bioma...

    Filing Type:    PU
    Outlook Corporate Consulting, LLC.

    Outlook Corporate Consulting, LLC.

    Business Minds Research & Development Corporate trains sales professionals, CEOs a...

    Business Minds Research & Development Corporate...

    Fundraising Status:    EC
    Filing Type:    CF
    dna ID, Inc.

    dna ID, Inc.

    The DNA ID platform is a community marketplace for genomics research. The app allo...

    The DNA ID platform is a community marketplace ...

    Amount Raised:    $57,589.00
    Fundraising Status:    EC
    Filing Type:    CF
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.